![]() | Mohammad A Rafi |
Prominent publications by Mohammad A Rafi
The human immunodeficiency virus type I (HIV-1) accessory protein Vpr has been associated with the induction of programmed cell death (apoptosis) and cell-cycle arrest. Studies have shown the apoptotic effect of Vpr on primary and established cell lines and on diverse tissues including the central nervous system (CNS) in vitro. However, the relevance of the effect of Vpr observed in vitro to HIV-1 neuropathogenesis in vivo, remains unknown. Due to the narrow host range of HIV-1 ...
Known for Hiv1 Vpr | Programmed Cell Death | Gene Products | Virus Animals | Human Immunodeficiency |
Globoid cell leukodystrophy, or Krabbe disease, is a severe, autosomal recessive disorder resulting from a deficiency of galactocerebrosidase (GALC) activity. GALC is responsible for the lysosomal catabolism of certain galactolipids, including galactosylceramide and psychosine. In addition to the human patients, there are several naturally occurring animal models for this disease, including the twitcher mouse, West Highland White terriers (WHWT), and Cairn terriers. All species have ...
Known for Galc Cdna | Globoid Cell | West Highland | Cairn Terriers | Mutation Causing |
Krabbe disease or globoid cell leukodystrophy (GLD) is a severe lysosomal disorder resulting from the deficiency of galactocerebrosidase (GALC) activity. This deficiency results in the insufficient catabolism of several galactolipids that are important in the production of normal myelin. Since the cloning of the human GALC cDNA and gene many disease-causing and polymorphic changes have been identified. This autosomal recessive disease has been reported to occur in several animal species, ...
Known for Globoid Cell | Krabbe Disease | Rhesus Monkey | Galc Cdna | Animal Species |
Galactocerebrosidase (GALC) is responsible for the lysosomal catabolism of certain galactolipids, including galactosylceramide and psychosine. Patients with GALC deficiency have an autosomal recessive disorder known as globoid cell leukodystrophy (GLD) or Krabbe disease. Storage of undegraded glycolipids results in defective myelin and the characteristic globoid cells observed on pathological examination of the central and peripheral nervous systems. Most patients have the infantile form ...
Known for Galc Activity | Cultured Dna | Gld Krabbe Disease | Retroviridae Transduction | Globoid Cell |
Globoid-cell leukodystrophy (GLD) is an autosomal recessive lysosomal storage disorder caused by mutations in the galactosylceramidase (GALC) gene. Infantile GLD has a lethal course with severe cerebral demyelination that progresses to death by 2 years of age. In the current study twitcher mice, an authentic murine model of infantile GLD, were given intracranial injections of either recombinant adeno-associated virus serotype 2 encoding the murine Galc cDNA (AAV2-GALC) or the same genome ...
Known for Murine Model | Cell Leukodystrophy | Cns Disease | Twitcher Mice | Aav2 5 |
Krabbe disease is an autosomal recessive disorder resulting from defects in the lysosomal enzyme galactocerebrosidase (GALC). GALC deficiency leads to severe neurological features. The only treatment for presymptomatic infantile patients and later-onset patients is hematopoietic stem cell transplantation (HSCT). This treatment is less than ideal with most patients eventually developing problems with gait and expressive language. Several naturally occurring animal models are available, ...
Known for Twitcher Mice | Cns Pns | Hsct Treatment | Intravenous Injection | Peripheral Nervous |
Galactocerebrosidase (GALC) is deficient in all tissues from human patients and animal models with globoid cell leukodystrophy (GLD) or Krabbe disease. The deficiency results in decreased lysosomal catabolism of certain galactolipids including galactosylceramide and psychosine that are synthesized maximally during myelination. According to current theories, the accumulation of psychosine in humans and animals with GLD induces oligodendrocyte degeneration and myelination ceases. ...
Known for Gene Transfer | Twitcher Mice | Glial Cells | Krabbe Disease | Human Patients |
Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy
[ PUBLICATION ]
Globoid cell leukodystrophy (GLD) or Krabbe disease is a neurodegenerative disorder caused by the deficiency of the lysosomal enzyme galactocerebrosidase (GALC). GALC deficiency results in a progressive demyelination of the central and peripheral nervous systems. Inflammatory cells and increased levels of cytokines and chemokines are present in the CNS of GLD mice and may play a significant role in the pathogenesis of the disease. In this study we evaluate the effect of non-steroidal ...
Known for Globoid Cell Leukodystrophy | Cell Mice | Anti Inflammatory | Krabbe Disease | Spinal Cord |
Extended Normal Life After AAVrh10-mediated Gene Therapy in the Mouse Model of Krabbe Disease
[ PUBLICATION ]
Globoid cell leukodystrophy (GLD) or Krabbe disease is a neurodegenerative disorder caused by the deficiency of the lysosomal enzyme galactocerebrosidase (GALC). This deficiency results in accumulation of certain galactolipids including psychosine which is cytotoxic for myelin-producing cells. Treatment of human patients at this time is limited to hematopoietic stem cell transplantation (HSCT) that appears to slow the progression of the disease when performed in presymptomatic patients. ...
Known for Mouse Model | Krabbe Disease | Gene Therapy | Human Patients | Treated Mice |
Globoid cell leukodystrophy (GLD) or Krabbe disease is an autosomal recessive disorder resulting from the defective lysosomal enzyme galactocerebrosidase (GALC). The lack of GALC enzyme leads to severe neurological symptoms. While most human patients are infants who do not survive beyond 2 years of age, older patients are also diagnosed. In addition to human patients, several naturally occurring animal models, including dog, mouse, and monkey, have also been identified. The mouse model ...
Known for Peripheral Nervous | Intravenous Injection | Human Patients | Krabbe Disease | Twitcher Mice |
Globoid cell leukodystrophy (GLD) or Krabbe disease is a neurodegenerative disorder caused by a deficiency of galactocerebrosidase (GALC) activity. GALC is required for the lysosomal degradation of galactosylceramide, psychosine, and possibly other galactolipids. This process is extremely important during active myelination. In the absence of functional GALC, psychosine accumulates, resulting in the apoptotic death of myelin-producing cells. While most patients are infants who do not ...
Known for Globoid Cell | Murine Models | Life Span | Gld Krabbe Disease | Galc Activity |
Mohammad A Rafi: Influence Statistics
Concept | World rank |
---|---|
successful treatment kd | #2 |
galc enzyme cns | #2 |
galactosylceramidase 20th | #2 |
galc cdna hsct | #2 |
copies galc | #2 |
galc providing | #2 |
genetic diseases focus | #2 |
adenoassociate viral vectors | #2 |
– krabbe | #2 |
combination stemcell technology | #2 |
nervous systems treatment | #2 |
sufficient galc enzyme | #2 |
presymptomatic human patients | #2 |
sessions gene therapy | #2 |
galactosylceramide major | #2 |
krabbe disease report | #2 |
transplantable cells body | #2 |
krabbe disease mutation | #2 |
galc genes | #2 |
brighter forecast | #2 |
krabbe 2016 | #2 |
sufficient galc | #2 |
sessions gene | #2 |
options transplantable | #2 |
longlived treated mice | #3 |
gld rhesus | #3 |
cells galactocerebrosidase | #3 |
characteristic storage cells | #3 |
length human galc | #3 |
neonate twi | #3 |
twi mice study | #3 |
twitcher glial cells | #3 |
dogs cdna position | #3 |
galc cdna identification | #3 |
correction galactocerebrosidase | #3 |
conditions murine model | #3 |
severe deficiency nucleotide | #3 |
pp284s | #3 |
greater promise combination | #3 |
pnd10 mice | #3 |
proteins arylsulfatase | #3 |
optimum conditions dosing | #3 |
pl81p | #3 |
extended normal life | #3 |
igf1 northern blotting | #3 |
primate krabbe | #3 |
survival galc activity | #3 |
canine galc cdna | #3 |
arylsulfatase sphingolipid | #3 |
new mutations cis | #3 |
Open the FULL List in Excel | |
Key People For Krabbe Disease
Mohammad A Rafi:Expert Impact
Concepts for whichMohammad A Rafihas direct influence:Krabbe disease, Globoid cell leukodystrophy, Globoid cell, Metachromatic leukodystrophy, Galc gene, Galc activity, Galc cdna, Gene therapy.
Mohammad A Rafi:KOL impact
Concepts related to the work of other authors for whichfor which Mohammad A Rafi has influence:Krabbe disease, Gene therapy, Globoid cell leukodystrophy, Central nervous, Lysosomal storage, Twitcher mice, Stem cell.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |